Prospects of oral anticoagulant therapy in patients with atrial fibrillation and chronic anemia: a narrative review

Prospects of oral anticoagulant therapy in patients with atrial fibrillation and chronic anemia: a narrative review

Anticoagulant therapy for atrial fibrillation (AF) plays an important role in preventing thromboembolic events. This review discusses anticoagulant therapy in patients with AF and chronic anemia of varying severity. The search was carried out in PubMed and Library electronic databases from 2010 to 2...

Full description

Saved in:

Bibliographic Details
Main Authors:	Tatyana S. Degtyareva, Kristina G. Pereverzeva, Sergey S. Yakushin, Natalia N. Peregudova
Format:	Article
Language:	English
Published:	Concilium Medicum 2024-12-01
Series:	КардиоСоматика
Subjects:	anemia atrial fibrillation oral anticoagulant therapy apixaban dabigatran etexilate rivaroxaban edoxaban oral anticoagulants
Online Access:	https://cardiosomatics.ru/2221-7185/article/viewFile/635908/pdf_1
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Control Of Anticoagulation Therapy in Atrial Fibrillation (COAT-AF Study) in Real Clinical Practice
by: A. A. Zarudsky, et al.
Published: (2020-03-01)

Elderly patient with atrial fibrillation and coronary risks
by: I. S. Yavelov
Published: (2021-07-01)

PHARMACOGENETIC ASPECTS OF NEW ORAL ANTICOAGULANTS APPLICATION
by: A. V. Kryukov, et al.
Published: (2017-07-01)

New safety standards for anticoagulant therapy in the treatment of atrial fibrillation
by: E. I. Baranova
Published: (2018-11-01)

ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: RECENT APPROACHES AND NEAR PERSPECTIVES
by: Ya. P. Dovgalevskiy, et al.
Published: (2016-01-01)

Current insights into the possible role of laboratory monitoring of effectiveness and safety of direct oral anticoagulants
by: S. R. Gilyarevsky, et al.
Published: (2023-07-01)

Safety of Non-Vitamin K Oral Anticoagulants in Elderly Patients with Atrial Fibrillation
by: M. A. Gabitova, et al.
Published: (2020-01-01)

PREDICTORS OF THE RISK OF HEMORRHAGIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION RECEIVING LONGTERM THERAPY WITH DIRECT ORAL ANTICOAGULANTS
by: A. А. Sokolova, et al.
Published: (2017-12-01)

Efficacy and Safety of Rivaroxaban, Apixaban, and Edoxaban for Nonvalvular Atrial Fibrillation Based on Blood Coagulation Activity and Drug Plasma Concentration: SETtsu and North Osaka Multicenter Direct Oral AntiCoagulant (SET DOAC) Registry
by: Michihiro Suwa, et al.
Published: (2024-10-01)

PRACTICAL APPLICATION OF DABIGATRAN ETEXILATE FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION
by: E. D. Kosmacheva, et al.
Published: (2015-09-01)

ANTICOAGULANT THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: DRUG CHOICE AND DOSAGE ADJUSTMENT
by: E. L. Dolgova, et al.
Published: (2015-09-01)

THE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION IN CLINICAL PRACTICE
by: S. V. Moiseev
Published: (2016-05-01)

Hospital consumption of direct oral anticoagulants in regions of the Russian Federation in 2017–2022
by: A. V. Matveev, et al.
Published: (2024-01-01)

The Efficacy, Safety and Adherence to Treatment when New Anticoagulants Taking in Over 75 Years Old Patients with Atrial Fibrillation
by: A. N. Turov, et al.
Published: (2020-03-01)

PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION
by: A. V. Rudakova
Published: (2015-09-01)

NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY
by: D. A. Napalkov, et al.
Published: (2015-09-01)

Use of direct oral anticoagulants in kidney diseases
by: I.A. Paliienko, et al.
Published: (2025-03-01)

Current approaches to periprocedural anticoagulation treatment in patients undergoing atrial fibrillation ablation
by: N. Z. Gasymova, et al.
Published: (2019-05-01)

Clinically Significant Drug Interactions for Direct Oral Anticoagulants: State of the Art
by: S. R. Gilyarevsky
Published: (2022-07-01)

Features of Modern Anticoagulant Therapy in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease
by: I. S. Daabul, et al.
Published: (2016-11-01)

EFFICACY AND SAFETY OF DIRECT ORAL ANTICOAGULANTS IN THE PREVENTION OF STROKE IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION IN EVERYDAY CLINICAL PRACTICE: FACTS ABOUT RIVAROXABAN
by: I. S. Yavelov
Published: (2016-07-01)

Drug interactions of non-vitamin K antagonist oral anticoagulants: inside and outside table cells
by: Sergey Nikolaevich Bel'diev, et al.
Published: (2017-11-01)

DRUG INTERACTIONS OF NEW ORAL ANTICOAGULANTS: INSIDE AND OUTSIDE TABLE CELLS
by: S. N. Bel'diev, et al.
Published: (2017-11-01)

Risk Factors of Gastrointestinal Bleeding in Patients Receiving New Oral Anticoagulants
by: Ju Yup Lee
Published: (2018-12-01)

Risk management in patients with atrial fibrillation and comorbid conditions: potentialities of edoxaban
by: O. L. Barbarash, et al.
Published: (2020-11-01)

DATA OF CLINICAL PRACTICE AS A TOOL FOR CHOICE OF DIRECT ORAL ANTICOAGULANT
by: D. А. Napalkov, et al.
Published: (2017-03-01)

DABIGATRAN ETEXILATE IN ELDERL Y PATIENTS WITH ATRIAL FIBRILLATION: WHATS NEW?
by: O. N. Tkacheva, et al.
Published: (2017-12-01)

EFFICACY AND SAFETY OF THE ORAL ANTICOAGULANTS IN THE MANAGEMENT OF VENOUS THROMBOEMBOLISM: INDIRECT COMPARISON
by: V. I. Petrov, et al.
Published: (2016-12-01)

THROMBOSIS OF LEFT ATRIAL APPENDAGE DURING THERAPY WITH DIRECT ORAL ANTICOAGULANT. CLINICAL CASE
by: I. S. Daaboul, et al.
Published: (2018-07-01)

SPECIFIC ANTIDOTES TO NEW ORAL ANTICOAGULANTS
by: O. O. Shakhmatova
Published: (2016-07-01)

Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Renal Dysfunction
by: Z. D. Kobalava, et al.
Published: (2021-03-01)

Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation in Real Clinical Practice: in Appropriate Dose Reductions
by: V. A. Ionin, et al.
Published: (2021-05-01)

Hepatotoxicity of New Oral Anticoagulants
by: A. R. Kasimova, et al.
Published: (2018-09-01)

Modern Anticoagulant Therapy for Atrial Fibrillation: Patient Adherence in Clinical Practice
by: Yu. P. Skirdenko, et al.
Published: (2022-03-01)

A STRATEGY FOR MANAGING A PATIENT WITH ATRIAL FIBRILLATION TO REDUCE THE RISK OF THROMBOEMBOLIC COMPLICATIONS
by: L. I. Kudryavtseva, et al.
Published: (2019-06-01)

Potential for anticoagulant therapy in the most vulnerable groups of patients
by: Irina A. Zolotovskaya, et al.
Published: (2022-02-01)

The Risk of Myocardial Infarction in Patients with Atrial Fibrillation Taking a Direct Thrombin Inhibitor: Myths and Reality
by: B. A. Tatarsky, et al.
Published: (2020-05-01)

ANALYSIS OF THE INFLUENCE OF THROMBOEMBOLIC COMPLICATIONS PREVENTION WITH ORAL ANTICOAGULANTS ON BUDGET IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
by: A. V. Rudakova
Published: (2015-09-01)

Factors associated with inappropriate reduced doses of non-vita-min K antagonist oral anticoagulants in patients with atrial fibrillation
by: V. A. Ionin, et al.
Published: (2021-10-01)

Specificities of Approaches to Anticoagulant Therapy in Comorbid Patients with Atrial Fibrillation, Diabetes Mellitus and Impaired Kidney Function
by: N. V. Drobotya, et al.
Published: (2020-05-01)